
Opinion|Videos|August 14, 2024
Combination Therapies and Intensifications of ADT in Advanced Prostate Cancer
The panel outlines combination therapy options for patients with advanced prostate cancer and discusses the potential benefits of intensification of androgen deprivation therapy.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
3
FDA approves generic Ga-68 PSMA-11 radiodiagnostic for prostate cancer
4
Benjamin Lowentritt, MD, reviews real-world testosterone recovery data with relugolix
5














